Fanny Piette

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

Sherene Loi, Nicolas Sirtaine, Fanny Piette et al. · Journal of Clinical Oncology · 2013 · 1.6K citations

Medicine, Immunology, Oncology +17

Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

Marc Buyse, Sherene Loi, Laura van’t Veer et al. · JNCI Journal of the National Cancer Institute · 2006 · 1.2K citations · Full text

Medicine, Bioinformatics, Oncology +14

Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

Christine Desmedt, Fanny Piette, Sherene Loi et al. · Clinical Cancer Research · 2007 · 985 citations

Medicine, Biostatistics, Oncology +17

Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation

Jacques Chapiro, Stéphane Claverol, Fanny Piette et al. · The Journal of Immunology · 2006 · 160 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Comparison of prognostic gene expression signatures for breast cancer

Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette et al. · BMC Genomics · 2008 · 139 citations · Full text

Medicine, Biostatistics, Oncology +17